SCHLACKMAN SCOTT 4
4 · MEDIFAST INC · Filed Mar 12, 2024
Insider Transaction Report
Form 4
MEDIFAST INCMED
SCHLACKMAN SCOTT
Director
Transactions
- Sale
Common Stock
2024-03-08$39.46/sh−2,753$108,633→ 7,784.707 total - Sale
Common Stock
2024-03-08$39.41/sh−1,300$51,233→ 10,537.707 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-08−1,300→ 0 totalExercise: $27.68Exp: 2026-02-04→ Common Stock (1,300 underlying) - Exercise/Conversion
Common Stock
2024-03-08$27.68/sh+1,300$35,984→ 11,837.707 total
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $39.38 to $39.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
- [F2]The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.